Described herein are compounds which exhibit progesterone antagonistic effects and methods of treating cancer using such compounds.

Described herein are compounds which either act as pure antiprogestins or as antiprogestins with partial agonistic activity and methods of treating cancer using such compounds.

The present invention relates to an oral pharmaceutical dosage form comprising micronized progesterone an edible oil a disintegrant and a hydrophilic excipient. Particularly the invention relates to a pharmaceutical dosage form wherein the dosage form is in a powder form and is contained in a pharmaceutically acceptable capsule. The present invention is also directed toward methods of making the dosage form methods of using the dosage form and kits comprising the dosage form.

The invention discloses a trace element solution, which comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium

The present invention relates to monolithic intravaginal rings comprising progesterone methods of making and uses thereof. The intravaginal rings comprise progesterone a polysiloxane elastomer and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.